Rathbones Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rathbones Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Hold	1,349	–	–	﹤0.01%	544
2025 Q4	$229K	Buy	+1,349	New	+$207K	﹤0.01%	554

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Rathbones Group's JAZZ Position: Q1 2026 in Review

Rathbones Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 1,349 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Rathbones Group first reported a position in JAZZ in Q4 2025 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Rathbones Group held 1,349 shares of Jazz Pharmaceuticals worth $255K as of Q1 2026.
Rathbones Group left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Rathbones Group's portfolio in Q1 2026, its #544 holding.
Rathbones Group first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.